Literature DB >> 19287155

Predisposition to colorectal cancer: exploiting copy number variation to identify novel predisposing genes and mechanisms.

R Venkatachalam1, M J L Ligtenberg, N Hoogerbrugge, A Geurts van Kessel, R P Kuiper.   

Abstract

Although cancer is mostly regarded as an acquired disease, familial predisposition plays a significant role in many cancer types. Thus far, several high penetrant cancer predisposing genes have been identified. As yet, however, these genes explain only a fraction of the familial and/or hereditary cases of cancer. This has led to the exploration of the human genome for novel cancer predisposing genes. The identification of such genes will not only increase our understanding of cancer predisposition and development, but will also have direct implications for genetic counseling and personalized management of the patients and their family members. Here we provide an inventory of currently known molecular mechanisms related to familial colorectal cancer development and an outline of copy number analysis-based strategies to identify new predisposing genes. Finally, we discuss a novel copy number-associated epigenetic mechanism underlying the predisposition to colorectal cancer. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19287155     DOI: 10.1159/000184708

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  5 in total

1.  Coexistence of copy number increases of ZNF217 and CYP24A1 in colorectal cancers in a Chinese population.

Authors:  Zhengyu Fang; Yi Xiong; Chao Zhang; Jiana Li; Li Liu; Manhui Li; Wei Zhang; Jun Wan
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

Review 2.  Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition.

Authors:  Manny D Bacolod; Francis Barany
Journal:  Ann Surg Oncol       Date:  2011-02-24       Impact factor: 5.344

3.  Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer.

Authors:  Lixia Xu; Xiaoxing Li; Muyan Cai; Jinna Chen; Xiangchun Li; William K K Wu; Wei Kang; Joanna Tong; Ka-Fai To; Xin-Yuan Guan; Joseph J Y Sung; Francis K L Chan; Jun Yu
Journal:  Gut       Date:  2015-05-06       Impact factor: 23.059

4.  A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations.

Authors:  Tao Xie; Giovanni D' Ario; John R Lamb; Eric Martin; Kai Wang; Sabine Tejpar; Mauro Delorenzi; Fred T Bosman; Arnaud D Roth; Pu Yan; Stephanie Bougel; Antonio Fabio Di Narzo; Vlad Popovici; Eva Budinská; Mao Mao; Scott L Weinrich; Paul A Rejto; J Graeme Hodgson
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

5.  Identification of copy number alterations in colon cancer from analysis of amplicon-based next generation sequencing data.

Authors:  Duarte Mendes Oliveira; Gianluca Santamaria; Carmelo Laudanna; Simona Migliozzi; Pietro Zoppoli; Michael Quist; Catie Grasso; Chiara Mignogna; Laura Elia; Maria Concetta Faniello; Cinzia Marinaro; Rosario Sacco; Francesco Corcione; Giuseppe Viglietto; Donatella Malanga; Antonia Rizzuto
Journal:  Oncotarget       Date:  2018-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.